Immunohistochemical Assessment of MGMT Expression and p53 Mutation in Glioblastoma Multiforme

Mousavi S. : Iranian Annual National Cancer Registration Report 2005–2006. Islamic Republic of Iran Ministry of Health and Medical Education Health Deputy, Center for Disease Control and Prevention. Cancer Office, Tehran, 2007.

Nakamura M. , Watanabe T. , Yonekawa Y. , Kleihues P. , Ohgaki H. : Promoter methylation of the DNA repair gene MGMT in astrocytomas is frequently associated with G: C —> A: T mutations of the TP53 tumor suppressor gene. Carcinogenesis, 22: 1715–1719, 2001.

Birner P. , Piribauer M. , Fischer I. , Gatterbauer B. , Marosi C. , Ungersbock K. , Rossler K. , Budka H. , Hainfellner J.A. : Prognostic relevance of p53 protein expression in glioblastoma. Oncol Rep, 9: 703–707, 2002.

Nayak A. , Ralte A.M. , Sharma M.C. , Singh V.P. , Mahapatra A.K. , Mehta V.S. , Sarkar C. : p53 protein alterations in adult astrocytic tumors and oligodendrogliomas. Neurol India, 52: 228–232, 2004.

Pfeifer G.P. : p53 mutational spectra and the role of methylated CpG sequences. Mutat Res, 450: 155–166, 2000.

Rolhion C. , Penault-Llorca F. , Kemeny J.L. , Kwiatkowski F. , Lemaire J.J. , Chollet P. , Finat-Duclos F. , Verrelle P. : O(6)-methylguanine-DNA methyltransferase gene (MGMT) expression in human glioblastomas in relation to patient characteristics and p53 accumulation. Int J Cancer, 84: 416–420, 1999.

Pegg A.E. : Repair of O(6)-alkylguanine by alkyltransferases. Mutat Res, 462: 83–100, 2000.

Luo Y. , Leverson J.D. : New opportunities in chemosensitization and radiosensitization: modulating the DNA-damage response. Expert Rev Anticancer Ther, 5: 333–342, 2005.

Alaoui-Jamali M. , Mitra S. : DNA repair and its regulatory pathways in cancer pharmacology. Les mécanismes de réparation de l'ADN: des cibles potentielles en pharmacologie du cancer. Médecine Sciences, 12: 766–773, 1996.

Esteller M. , Toyota M. , Sanchez-Cespedes M. , Capella G. , Peinado M.A. , Watkins D.N. , Issa J.P. , Sidransky D. , Baylin S.B. , Herman J.G. : Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is associated with G to A mutations in K-ras in colorectal tumorigenesis. Cancer Res, 60: 2368–2371, 2000.

Mitsumori K. , Onodera H. , Shimo T. , Yasuhara K. , Takagi H. , Koujitani T. , Hirose M. , Maruyama C. , Wakana S. : Rapid induction of uterine tumors with p53 point mutations in heterozygous p53-deficient CBA mice given a single intraperitoneal administration of N-ethyl-N-nitrosourea. Carcinogenesis, 21: 1039–1042, 2000.

Srivenugopal K.S. , Shou J. , Mullapudi S.R. , Lang F.F. Jr. , Rao J.S. , Ali-Osman F. : Enforced expression of wild-type p53 curtails the transcription of the O(6)-methylguanine-DNA methyltransferase gene in human tumor cells and enhances their sensitivity to alkylating agents. Clin Cancer Res, 7: 1398–1409, 2001.

Harris L.C. , Remack J.S. , Houghton P.J. , Brent T.P. : Wild-type p53 suppresses transcription of the human O6-methylguanine-DNA methyltransferase gene. Cancer Res, 56: 2029–2032, 1996.

Gao J.P. , Uchida T. , Wang C. , Jiang S.X. , Matsumoto K. , Satoh T. , Minei S. , Soh S. , Kameya T. , Baba S. : Relationship between p53 gene mutation and protein expression: clinical significance in transitional cell carcinoma of the bladder. Int J Oncol, 16: 469–475, 2000.

Shamsara J. , Sharif S. , Afsharnezhad S. , Lotfi M. , Raziee H.R. , Ghaffarzadegan K. , Morad A. , Rahighi S. , Behravan J. : Association between MGMT promoter hypermethylation and p53 mutation in glioblastoma. Cancer Invest, 27: 825–829, 2009.

Brell M. , Tortosa A. , Verger E. , Gil J.M. , Vinolas N. , Villa S. , Acebes J.J. , Caral L. , Pujol T. , Ferrer I. , Ribalta T. , Graus F. : Prognostic significance of O6-methylguanine-DNA methyltransferase determined by promoter hypermethylation and immunohistochemical expression in anaplastic gliomas. Clin Cancer Res, 11: 5167–5174, 2005.

Hegi M.E. , Diserens A.C. , Gorlia T. , Hamou M.F. , de Tribolet N. , Weller M. , Kros J.M. , Hainfellner J.A. , Mason W. , Mariani L. , Bromberg J.E. , Hau P. , Mirimanoff R.O. , Cairncross J.G. , Janzer R.C. , Stupp R. : MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med, 352: 997–1003, 2005.

Esteller M. , Risques R.A. , Toyota M. , Capella G. , Moreno V. , Peinado M.A. , Baylin S.B. , Herman J.G. : Promoter hypermethylation of the DNA repair gene O(6)-methylguanine-DNA methyltransferase is associated with the presence of G: C to A: T transition mutations in p53 in human colorectal tumorigenesis. Cancer Res, 61: 4689–4692, 2001.

de Castro Ribeiro M. , Barbosa Coutinho L.M. , Hilbig A. : The role of apoptosis, cell proliferation index, bcl-2, and p53 in glioblastoma prognosis. Arq Neuro-Psiquiatr, 62: 262–270, 2004.

Pollack I.F. , Finkelstein S.D. , Woods J. , Burnham J. , Holmes E.J. , Hamilton R.L. , Yates A.J. , Boyett J.M. , Finlay J.L. , Sposto R. : Expression of p53 and prognosis in children with malignant gliomas. N Engl J Med, 346: 420–427, 2002.

Pollack I.F. , Hamilton R.L. , Finkelstein S.D. , Campbell J.W. , Martinez A.J. , Sherwin R.N. , Bozik M.E. , Gollin S.M. : The relationship between TP53 mutations and overexpression of p53 and prognosis in malignant gliomas of childhood. Cancer Res, 57: 304–309, 1997.

Hirose Y. , Berger M.S. , Pieper R.O. : p53 effects both the duration of G2/M arrest and the fate of temozolomide-treated human glioblastoma cells. Cancer Res, 61: 1957–1963, 2001.

Biroccio A. , Bufalo D.D. , Ricca A. , D'Angelo C. , D'Orazi G. , Sacchi A. , Soddu S. , Zupi G. : Increase of BCNU sensitivity by wt-p53 gene therapy in glioblastoma lines depends on the administration schedule. Gene Ther, 6: 1064–1072, 1999.

Yuan Q. , Matsumoto K. , Nakabeppu Y. , Iwaki T. : A comparative immunohistochemistry of O6-methylguanine-DNA methyltransferase and p53 in diffusely infiltrating astrocytomas. Neuropathology, 23: 203–209, 2003.

Hermisson M. , Klumpp A. , Wick W. , Wischhusen J. , Nagel G. , Roos W. , Kaina B. , Weller M. : O6-methylguanine DNA methyltransferase and p53 status predict temozolomide sensitivity in human malignant glioma cells. J Neurochem, 96: 766–776, 2006.

Blough M.D. , Zlatescu M.C. , Cairncross J.G. : O6-methylguanine-DNA methyltransferase regulation by p53 in astrocytic cells. Cancer Res, 67: 580–584, 2007.

Grombacher T. , Eichhorn U. , Kaina B. : p53 is involved in regulation of the DNA repair gene O6-methylguanine-DNA methyltransferase (MGMT) by DNA damaging agents. Oncogene, 17: 845–851, 1998.

Nutt C.L. , Loktionova N.A. , Pegg A.E. , Chambers A.F. , Cairncross J.G. : O(6)-methylguanine-DNA methyltransferase activity, p53 gene status and BCNU resistance in mouse astrocytes. Carcinogenesis, 20: 2361–2365, 1999.

Wiewrodt D. , Nagel G. , Dreimuller N. , Hundsberger T. , Perneczky A. , Kaina B. : MGMT in primary and recurrent human glioblastomas after radiation and chemotherapy and comparison with p53 status and clinical outcome. Int J Cancer, 122: 1391–1399, 2008.

Russell S.J. , Ye Y.W. , Waber P.G. , Shuford M. , Schold S.C. Jr. , Nisen P.D. : p53 mutations, O6-alkylguanine DNA alkyltransferase activity, and sensitivity to procarbazine in human brain tumors. Cancer, 75: 1339–1334, 1995.

Rafferty J.A. , Clarke A.R. , Sellappan D. , Koref M.S. , Frayling I.M. , Margison G.P. : Induction of murine O6-alkylguanine-DNA-alkyltransferase in response to ionising radiation is p53 gene dose dependent. Oncogene, 12: 693–697, 1996.

Wolf P. , Hu Y.C. , Doffek K. , Sidransky D. , Ahrendt S.A. : O(6)-Methylguanine-DNA methyltransferase promoter hypermethylation shifts the p53 mutational spectrum in non-small cell lung cancer. Cancer Res, 61: 8113–8117, 2001.